Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.84B
| $1.64M | ﹤0.01% |
25,300
+2,400
| +10% | +$148K |
|
|
AFCG
2202
AFC Gamma
AFCG
$72.1M
| $1.64M | ﹤0.01% |
152,236
+12,564
| +9% | +$141K |
|
2203
Crown Crafts
CRWS
$30.7M
| $1.64M | ﹤0.01% |
306,942
-14,176
| -4% | -$81.6K |
|
2204
Ligand Pharmaceuticals
LGND
$5.87B
| $1.64M | ﹤0.01% |
24,500
-2,270
| -8% | -$148K |
|
2205
Sypris Solutions
SYPR
$47.4M
| $1.64M | ﹤0.01% |
798,021
-35,008
| -4% | -$72.9K |
|
2206
Kura Sushi USA
KRUS
$643M
| $1.63M | ﹤0.01% |
34,157
-21,043
| -38% | -$1.4M |
|
2207
PCB Bancorp
PCB
$399M
| $1.63M | ﹤0.01% |
91,998
-2,303
| -2% | -$42.9K |
|
|
HA
2208
DELISTED
Hawaiian Holdings, Inc.
HA
| $1.63M | ﹤0.01% |
158,600
+65,300
| +70% | +$872K |
|
2209
Riverview Bancorp
RVSB
$106M
| $1.63M | ﹤0.01% |
211,607
-15,200
| -7% | -$108K |
|
|
AHT
2210
Ashford Hospitality Trust
AHT
$20.8M
| $1.62M | ﹤0.01% |
36,297
+560
| +2% | +$36.1K |
|
2211
Citizens & Northern Corp
CZNC
$466M
| $1.62M | ﹤0.01% |
70,741
-4,800
| -6% | -$115K |
|
2212
Alamo Group
ALG
$2.01B
| $1.61M | ﹤0.01% |
11,400
+2,100
| +23% | +$304K |
|
2213
Glaukos
GKOS
$10.9B
| $1.61M | ﹤0.01% |
36,765
-66,435
| -64% | -$3.28M |
|
2214
Innoviz Technologies
INVZ
$107M
| $1.61M | ﹤0.01% |
408,600
+38,400
| +10% | +$183K |
|
2215
Annexon
ANNX
$1B
| $1.6M | ﹤0.01% |
310,100
-20,100
| -6% | -$110K |
|
|
NSTG
2216
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.6M | ﹤0.01% |
+200,500
| New | +$1.74M |
|
2217
Schwab US Dividend Equity ETF
SCHD
$108B
| $1.59M | ﹤0.01% |
63,300
-68,100
| -52% | -$1.68M |
|
2218
MasterCraft Boat Holdings
MCFT
$605M
| $1.59M | ﹤0.01% |
61,400
+8,700
| +17% | +$205K |
|
2219
Princeton Bancorp
BPRN
$296M
| $1.58M | ﹤0.01% |
49,965
+4,142
| +9% | +$129K |
|
|
KE
2220
Kimball Electronics
KE
$622M
| $1.58M | ﹤0.01% |
70,175
-10,100
| -13% | -$216K |
|
2221
BBVA Argentina
BBAR
$3.13B
| $1.58M | ﹤0.01% |
405,786
+169,620
| +72% | +$523K |
|
2222
CAE Inc
CAE
$8.43B
| $1.58M | ﹤0.01% |
81,800
-576,946
| -88% | -$11.1M |
|
2223
Samsara
IOT
$23.2B
| $1.58M | ﹤0.01% |
+127,300
| New | +$1.45M |
|
2224
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
| $1.58M | ﹤0.01% |
89,800
+14,900
| +20% | +$254K |
|
|
ALEX
2225
DELISTED
Alexander & Baldwin
ALEX
| $1.58M | ﹤0.01% |
84,300
-39,400
| -32% | -$746K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 522 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 522 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.